StockData
AgomAb Therapeutics NV logo

AgomAb Therapeutics NV (AGMB) stock

AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 23, 2026Score 2/30
$5.82−0.10 (-1.69%)

Close on Nov 18, 2026Market cap $145.50KP/E –Yield –

AgomAb Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

AgomAb Therapeutics's market cap was $174.75K on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$174.75K–

More AgomAb Therapeutics figures

See a number that looks wrong?